A Systematic Literature Review of the Prognostic and Predictive Value of PIK3CA Mutations in HR+/HER2− Metastatic Breast Cancer

MLA

Ayal A. Aizer, et al. “A Systematic Literature Review of the Prognostic and Predictive Value of PIK3CA Mutations in HR+/HER2− Metastatic Breast Cancer.” Clinical Breast Cancer, vol. 20, June 2020, pp. e232–43. EBSCOhost, https://doi.org/10.1016/j.clbc.2019.08.011.

APA

Ayal A. Aizer, Terri L. Warholak, Joni L. Dean, Lea Mollon, Derek H. Tang, Elizabeth Anderson, Lisa E. Davis, & Emma Platt. (2020). A Systematic Literature Review of the Prognostic and Predictive Value of PIK3CA Mutations in HR+/HER2− Metastatic Breast Cancer. Clinical Breast Cancer, 20, e232–e243. https://doi.org/10.1016/j.clbc.2019.08.011

Chicago

Ayal A. Aizer, Terri L. Warholak, Joni L. Dean, Lea Mollon, Derek H. Tang, Elizabeth Anderson, Lisa E. Davis, and Emma Platt. 2020. “A Systematic Literature Review of the Prognostic and Predictive Value of PIK3CA Mutations in HR+/HER2− Metastatic Breast Cancer.” Clinical Breast Cancer 20 (June): e232–43. doi:10.1016/j.clbc.2019.08.011.